These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 21707826

  • 1. Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies.
    Pawate S, Wang L, Song Y, Sriram S.
    J Neuroimaging; 2012 Apr; 22(2):137-44. PubMed ID: 21707826
    [Abstract] [Full Text] [Related]

  • 2. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.
    Bakshi R, Benedict RH, Bermel RA, Caruthers SD, Puli SR, Tjoa CW, Fabiano AJ, Jacobs L.
    Arch Neurol; 2002 Jan; 59(1):62-8. PubMed ID: 11790232
    [Abstract] [Full Text] [Related]

  • 3. Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).
    Du S, Sah SK, Zeng C, Wang J, Liu Y, Xiong H, Li Y.
    Eur J Radiol; 2015 Jul; 84(7):1325-32. PubMed ID: 25959392
    [Abstract] [Full Text] [Related]

  • 4. Age-dependent changes in brain iron deposition and volume in deep gray matter nuclei using quantitative susceptibility mapping.
    Li G, Tong R, Zhang M, Gillen KM, Jiang W, Du Y, Wang Y, Li J.
    Neuroimage; 2023 Apr 01; 269():119923. PubMed ID: 36739101
    [Abstract] [Full Text] [Related]

  • 5. A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
    Khalid F, Tauhid S, Chua AS, Healy BC, Stankiewicz JM, Weiner HL, Bakshi R.
    Int J Neurosci; 2017 May 01; 127(5):396-403. PubMed ID: 27143245
    [Abstract] [Full Text] [Related]

  • 6. Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
    Chu R, Hurwitz S, Tauhid S, Bakshi R.
    BMC Neurol; 2017 Sep 05; 17(1):172. PubMed ID: 28874119
    [Abstract] [Full Text] [Related]

  • 7. Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis.
    Zhang Y, Zabad R, Wei X, Metz L, Hill M, Mitchell J.
    Mult Scler; 2007 Aug 05; 13(7):880-3. PubMed ID: 17468444
    [Abstract] [Full Text] [Related]

  • 8. Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome: a 7 Tesla MRI study.
    Blazejewska AI, Al-Radaideh AM, Wharton S, Lim SY, Bowtell RW, Constantinescu CS, Gowland PA.
    J Magn Reson Imaging; 2015 Apr 05; 41(4):1065-70. PubMed ID: 24841344
    [Abstract] [Full Text] [Related]

  • 9. Natalizumab therapy for highly active pediatric multiple sclerosis.
    Kornek B, Aboul-Enein F, Rostasy K, Milos RI, Steiner I, Penzien J, Hellwig K, Pitarokoili K, Storm van's Gravesande K, Karenfort M, Blaschek A, Meyer A, Seidl R, Debelic D, Vass K, Prayer D, Kristoferitsch W, Bayas A.
    JAMA Neurol; 2013 Apr 05; 70(4):469-75. PubMed ID: 23420110
    [Abstract] [Full Text] [Related]

  • 10. The clinical meaning of walking speed as measured by the timed 25-foot walk in patients with multiple sclerosis.
    Cohen JA, Krishnan AV, Goodman AD, Potts J, Wang P, Havrdova E, Polman C, Rudick RA.
    JAMA Neurol; 2014 Nov 05; 71(11):1386-93. PubMed ID: 25178496
    [Abstract] [Full Text] [Related]

  • 11. High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents.
    Ramalho J, Castillo M, AlObaidy M, Nunes RH, Ramalho M, Dale BM, Semelka RC.
    Radiology; 2015 Sep 05; 276(3):836-44. PubMed ID: 26079490
    [Abstract] [Full Text] [Related]

  • 12. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis.
    Tjoa CW, Benedict RH, Weinstock-Guttman B, Fabiano AJ, Bakshi R.
    J Neurol Sci; 2005 Jul 15; 234(1-2):17-24. PubMed ID: 15993137
    [Abstract] [Full Text] [Related]

  • 13. Differential changes in deep and cortical gray matters of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.
    Zhou F, Zee CS, Gong H, Shiroishi M, Li J.
    J Comput Assist Tomogr; 2010 Jul 15; 34(3):431-6. PubMed ID: 20498549
    [Abstract] [Full Text] [Related]

  • 14. MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study.
    Fox RJ, Cree BA, De Sèze J, Gold R, Hartung HP, Jeffery D, Kappos L, Kaufman M, Montalbán X, Weinstock-Guttman B, Anderson B, Natarajan A, Ticho B, Duda P, RESTORE.
    Neurology; 2014 Apr 29; 82(17):1491-8. PubMed ID: 24682966
    [Abstract] [Full Text] [Related]

  • 15. Age and sex related differences in subcortical brain iron concentrations among healthy adults.
    Persson N, Wu J, Zhang Q, Liu T, Shen J, Bao R, Ni M, Liu T, Wang Y, Spincemaille P.
    Neuroimage; 2015 Nov 15; 122():385-98. PubMed ID: 26216277
    [Abstract] [Full Text] [Related]

  • 16. Iron deposition of the deep grey matter in patients with multiple sclerosis and neuromyelitis optica: a control quantitative study by 3D-enhanced susceptibility-weighted angiography (ESWAN).
    Chen X, Zeng C, Luo T, Ouyang Y, Lv F, Rumzan R, Wang Z, Li Q, Wang J, Hou H, Huang F, Li Y.
    Eur J Radiol; 2012 Apr 15; 81(4):e633-9. PubMed ID: 22280874
    [Abstract] [Full Text] [Related]

  • 17. Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis.
    Rinaldi F, Calabrese M, Seppi D, Puthenparampil M, Perini P, Gallo P.
    Mult Scler; 2012 Dec 15; 18(12):1760-7. PubMed ID: 22570359
    [Abstract] [Full Text] [Related]

  • 18. Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis.
    Prosperini L, Giannì C, Leonardi L, De Giglio L, Borriello G, Galgani S, Pozzilli C, Gasperini C.
    Mult Scler; 2012 Jan 15; 18(1):64-71. PubMed ID: 21828195
    [Abstract] [Full Text] [Related]

  • 19. Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
    Iaffaldano P, Lucisano G, Pozzilli C, Brescia Morra V, Ghezzi A, Millefiorini E, Patti F, Lugaresi A, Zimatore GB, Marrosu MG, Amato MP, Bertolotto A, Bergamaschi R, Granella F, Coniglio G, Tedeschi G, Sola P, Lus G, Ferrò MT, Iuliano G, Corea F, Protti A, Cavalla P, Guareschi A, Rodegher M, Paolicelli D, Tortorella C, Lepore V, Prosperini L, Saccà F, Baroncini D, Comi G, Trojano M, Italian iMed-Web database.
    Brain; 2015 Nov 15; 138(Pt 11):3275-86. PubMed ID: 26362907
    [Abstract] [Full Text] [Related]

  • 20. Weekly enhanced T1-weighted MRI with Gadobutrol injections in MS patients: Is there a signal intensity increase in the dentate nucleus and the globus pallidus?
    Jaulent P, Hannoun S, Kocevar G, Rollot F, Durand-Dubief F, Vukusic S, Brisset JC, Sappey-Marinier D, Cotton F.
    Eur J Radiol; 2018 Aug 15; 105():204-208. PubMed ID: 30017281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.